Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Embla Medical hf Proxy Solicitation & Information Statement 2021

Mar 5, 2021

8210_rns_2021-03-05_d739452f-d75e-4106-9aed-4cf93cc02b17.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

ÖSSUR. LIFE WITHOUT LIMITATIONS

Össur hf: Candidates to the Board of Directors

Announcement no. 06/2021

5 March 2021

Candidates to the Board of Directors

Enclosed are details on the candidates to the Board of Directors of Össur hf., to be elected at the Annual General Meeting held on Monday, 8 March 2021, at 9:00 am (GMT). The Annual General Meeting will be fully virtual as previously announced.

Further information

Edda Lára Lúðvigsdóttir, Investor Relations, [email protected], +354844 4759

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors

About Össur

Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations. A recognized "Technology Pioneer" with a rich 50-year history, Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women's Empowerment Principles, contributes to the UN Sustainable Development Goals and will be carbon neutral in 2021. Össur operates globally and employs around 3,500 employees. www.ossur.com